The evidence that FOLR1 is causally linked to the C/G fusion and uniquely expressed in AML blasts suggested that targeting FOLR1 may provide a specific strategy to eliminate C/G leukemia without impacting normal hematopoiesis. Here, FOLR1 is linked to acute myeloid leukemia.